Trials / Completed
CompletedNCT03766035
Cholangioscopy in Primary Sclerosing Cholangitis (PSC)
- Status
- Completed
- Phase
- —
- Study type
- Observational
- Enrollment
- 43 (actual)
- Sponsor
- Boston Scientific Corporation · Industry
- Sex
- All
- Age
- 18 Years
- Healthy volunteers
- Not accepted
Summary
To demonstrate the clinical utility of the addition of per oral cholangioscopy (POCS) to standard endoscopic retrograde cholangiopancreatography (ERCP) with brushing cytology for diagnosis and early detection of cholangiocarcinoma in patients diagnosed with primary sclerosing cholangitis (PSC).
Detailed description
The primary objective of this study is to demonstrate the clinical utility of the addition of per oral cholangioscopy (POCS) to standard ERCP with brushing cytology for diagnosis and early detection of cholangiocarcinoma in patients diagnosed with primary sclerosing cholangitis (PSC).
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DEVICE | SpyGlass DS I - II | The SpyScope™ DS Access and Delivery Catheter (SpyScope™ DS Catheter) is a sterile, single-use endoscope that enables access and delivery of accessories to targeted pancreaticobiliary anatomy and displays live video when connected to a Spy Glass DS Digital Controller. |
Timeline
- Start date
- 2018-12-06
- Primary completion
- 2022-12-12
- Completion
- 2022-12-12
- First posted
- 2018-12-05
- Last updated
- 2023-01-25
Locations
6 sites across 4 countries: United States, Canada, Netherlands, Norway
Regulatory
- FDA-regulated device study
Source: ClinicalTrials.gov record NCT03766035. Inclusion in this directory is not an endorsement.